grekovВестник хирургии имени И.И. ГрековаGrekov's Bulletin of Surgery0042-46252686-7370Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russia10.24884/0042-4625-2017-176-2-119-123grekov-333Research ArticleОБЗОРЫREVIEWSРИСКИ ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ В ХИРУРГИИRisks of development of thrombotic complications in surgeryФилипповаО. И.FilippovaO. I.milidoctor@mail.ruКолосковА. В.KoloskovA. V.Andrei.Koloskov@szgmu.ruСеверо-Западный государственный медицинский университет им. И. И. МечниковаРоссияI. I. Mechnikov North-Western State Medical UniversityRussian Federation2017280420171762119123Copyright © Филиппова О.И., Колосков А.В., 20172017Филиппова О.И., Колосков А.В.Filippova O.I., Koloskov A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vestnik-grekova.ru/jour/article/view/333тромбозтромбофилияфакторы рискахирургияthrombosisthrombophiliarisk factorssurgeryReferencesБаркаган З. С., Момот А. П. Диагностика и контролирующая терапия нарушений гемостаза. М.: Ньюдиамед, 2008. 292 с.Баркаган З. С., Момот А. П. Диагностика и контролирующая терапия нарушений гемостаза. М.: Ньюдиамед, 2008. 292 с.Борин В. В., Шипаков В. Е. Роль послеоперационного обезболивания в профилактике тромботических осложнений при эндопротезировании тазобедренного сустава // Медицина и образование в Сибири. 2013. № 3. С. 22-30.Борин В. В., Шипаков В. Е. Роль послеоперационного обезболивания в профилактике тромботических осложнений при эндопротезировании тазобедренного сустава // Медицина и образование в Сибири. 2013. № 3. С. 22-30.Колосков А. В., Батурина О. А., Лыщев А. А. и др. Тромботические и геморрагические риски у беременных женщин // MEDLINE. RU: сетевой журнал. 2013. Т. 14. С. 880-890.Колосков А. В., Батурина О. А., Лыщев А. А. и др. Тромботические и геморрагические риски у беременных женщин // MEDLINE. RU: сетевой журнал. 2013. Т. 14. С. 880-890.Колосков А. В., Филиппова О. И., Лыщев А. А. и др. Частота встречаемости полиморфизмов гена фактора V (A506G), гена протромбина (G20210A) и гена MTHFR (C677ТИ A1298С) у здоровых доноров крови Санкт-Петербурга // MEDLINE. RU: сетевой журнал. 2015. Т. 16. С. 682-689.Колосков А. В., Филиппова О. И., Лыщев А. А. и др. Частота встречаемости полиморфизмов гена фактора V (A506G), гена протромбина (G20210A) и гена MTHFR (C677ТИ A1298С) у здоровых доноров крови Санкт-Петербурга // MEDLINE. RU: сетевой журнал. 2015. Т. 16. С. 682-689.Овечкин А. М., Карпов И. А., Люосев С. В. Послеоперационное обезболивание в абдоминальной хирургии: новый взгляд на старую проблему // Анестезиол. и реаниматол. 2003. Т. 5. С. 45-50.Овечкин А. М., Карпов И. А., Люосев С. В. Послеоперационное обезболивание в абдоминальной хирургии: новый взгляд на старую проблему // Анестезиол. и реаниматол. 2003. Т. 5. С. 45-50.Ay C., Vormittag R., Dunkler D. et al. D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and thrombosis study // J. Clin. Oncol. 2009. Vol. 27, № 25. P. 4124-4129.Ay C., Vormittag R., Dunkler D. et al. D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and thrombosis study // J. Clin. Oncol. 2009. Vol. 27, № 25. P. 4124-4129.Bates S. M., Greer I. A., Hirsh J., Gingsberg J. S. Use of anti-thrombotic agents during pregnancy // Chest. 2004. Vol. 126, № 3. P. 627-644.Bates S. M., Greer I. A., Hirsh J., Gingsberg J. S. Use of anti-thrombotic agents during pregnancy // Chest. 2004. Vol. 126, № 3. P. 627-644.Bernardo A., Ball C., Nolasco L. et al. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow // Blood. 2004. Vol. 104, № 1. P. 100-106.Bernardo A., Ball C., Nolasco L. et al. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow // Blood. 2004. Vol. 104, № 1. P. 100-106.Camaioni C., Gustapane M., Cialdella P. et al. Microparticles and microRNAs: new players in the complex field of coagulation // Intern. Emerg. Med. 2013. Vol. 8, № 4. P. 291-296.Camaioni C., Gustapane M., Cialdella P. et al. Microparticles and microRNAs: new players in the complex field of coagulation // Intern. Emerg. Med. 2013. Vol. 8, № 4. P. 291-296.Cervantes J., Rojas G. Virchow’s legacy: deep vein thrombosis and pulmonary embolism // World J. Surg. 2005. Vol. 29, Suppl. 1. P. 30-34.Cervantes J., Rojas G. Virchow’s legacy: deep vein thrombosis and pulmonary embolism // World J. Surg. 2005. Vol. 29, Suppl. 1. P. 30-34.Cosman F., Baz-Hecht M., Cushman M. et al. Short term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature // Thromb. Res. 2005. Vol. 116, № 1. P. 1-13.Cosman F., Baz-Hecht M., Cushman M. et al. Short term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature // Thromb. Res. 2005. Vol. 116, № 1. P. 1-13.Esmon C. T. The interactions between inflammation and coagulation // Brit. J. Haematol. 2005 Vol. 131. № 4. P. 417-430.Esmon C. T. The interactions between inflammation and coagulation // Brit. J. Haematol. 2005 Vol. 131. № 4. P. 417-430.Falanga A. Coagulation and cancer: biological and clinical aspects // J. Thromb. Haemost. 2012. Vol. 11, № 2. P. 223-233.Falanga A. Coagulation and cancer: biological and clinical aspects // J. Thromb. Haemost. 2012. Vol. 11, № 2. P. 223-233.Ferreira I. A., Mocking A. I., Feijge M. A. et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus // Arterioscler. Thromb. Vasc. Biol. 2006. Vol. 26, № 2. P. 417-422.Ferreira I. A., Mocking A. I., Feijge M. A. et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus // Arterioscler. Thromb. Vasc. Biol. 2006. Vol. 26, № 2. P. 417-422.Freyssinet J. M., Toti F. Formation of procoagulant microparticles and properties // Thromb. Res. 2010. Vol. 125, Suppl. 1. P. 46-48.Freyssinet J. M., Toti F. Formation of procoagulant microparticles and properties // Thromb. Res. 2010. Vol. 125, Suppl. 1. P. 46-48.Grady D., Weger N., Herrington D. Postmenopausal hormone therapy increases risk for venous thromboembolic disease // Ann. Intern. Med. 2000. Vol. 132, № 9. P. 689-696.Grady D., Weger N., Herrington D. Postmenopausal hormone therapy increases risk for venous thromboembolic disease // Ann. Intern. Med. 2000. Vol. 132, № 9. P. 689-696.Hippisley-Cox J., Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study // BMJ. 2011. Vol. 343. doi: 10.1136/bmj.d4656.Hippisley-Cox J., Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study // BMJ. 2011. Vol. 343. doi: 10.1136/bmj.d4656.Inai K., Noriki S, Iwasaki H. Should prophylactic thrombolysis be routine in clinical practice? Evidence from an autopsy case of septicemia // BMC Clin. Pathol. 2014. Vol. 14, № 1.6. doi: 10.1186/1472-6890-14-6.Inai K., Noriki S, Iwasaki H. Should prophylactic thrombolysis be routine in clinical practice? Evidence from an autopsy case of septicemia // BMC Clin. Pathol. 2014. Vol. 14, № 1.6. doi: 10.1186/1472-6890-14-6.Horsted F., West J., Grainge M. J. Risk of venous thromboembolism in patients with cancer: a systematic review and metaanalysis // PLoS Med. 2012. Vol. 9 № 7. P. e1001275. doi: 10.1371/ journal.pmed.1001275.Horsted F., West J., Grainge M. J. Risk of venous thromboembolism in patients with cancer: a systematic review and metaanalysis // PLoS Med. 2012. Vol. 9 № 7. P. e1001275. doi: 10.1371/ journal.pmed.1001275.Kemmeren J. M., Algra A., Meijers J. C. et al. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation // Thromb. Haemost. 2002. Vol. 87, № 2. P. 199-205.Kemmeren J. M., Algra A., Meijers J. C. et al. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation // Thromb. Haemost. 2002. Vol. 87, № 2. P. 199-205.Khorana A. A., Kuderer N. M., Culakova E. et al. Development and validation of a predictive model for chemotherapy-associated thrombosis // Blood. 2008. Vol. 111, № 10. P. 4902-4907.Khorana A. A., Kuderer N. M., Culakova E. et al. Development and validation of a predictive model for chemotherapy-associated thrombosis // Blood. 2008. Vol. 111, № 10. P. 4902-4907.Levi M., van der Poll T. Inflammation and coagulation // Crit. Care Med. 2010. Vol. 3, № 2. P. 26-34.Levi M., van der Poll T. Inflammation and coagulation // Crit. Care Med. 2010. Vol. 3, № 2. P. 26-34.Lip G. Y., Nieuwlaat R., Pisters R. et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation // Chest. 2010. Vol. 137, № 2. P. 263-272.Lip G. Y., Nieuwlaat R., Pisters R. et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation // Chest. 2010. Vol. 137, № 2. P. 263-272.Lyman G. H., Khorana A. A., Falanga A. Thrombosis and cancer: emerging data for the practicing oncologist // Amer. Soc. Clin. Oncol. Educ. Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e337Lyman G. H., Khorana A. A., Falanga A. Thrombosis and cancer: emerging data for the practicing oncologist // Amer. Soc. Clin. Oncol. Educ. Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e337Middeldorp S., Meijers J. C., van den Ende A. et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study // Thromb. Haemost. 2000. Vol. 84, № 1. P. 4-8.Middeldorp S., Meijers J. C., van den Ende A. et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study // Thromb. Haemost. 2000. Vol. 84, № 1. P. 4-8.Mousa S. A. Role of current and emerging antithrombotics in thrombosis and cancer // Drugs Today(Barc.). 2006. Vol. 42, № 5. P. 331-350.Mousa S. A. Role of current and emerging antithrombotics in thrombosis and cancer // Drugs Today(Barc.). 2006. Vol. 42, № 5. P. 331-350.Nemeth B., van Adrichem R. A., van Hylckama Vlieg A. et al. Venous thrombosis risk after cast immobilization of the lower extremity: derivation and validation of a clinical prediction score, L-TRiP(cast), in three population-based case-control studies // PLoS. Med. 2015. Vol. 12, № 11. P. e1001899. doi: 10.1371/journal.pmed.1001899.Nemeth B., van Adrichem R. A., van Hylckama Vlieg A. et al. Venous thrombosis risk after cast immobilization of the lower extremity: derivation and validation of a clinical prediction score, L-TRiP(cast), in three population-based case-control studies // PLoS. Med. 2015. Vol. 12, № 11. P. e1001899. doi: 10.1371/journal.pmed.1001899.Opal S. M. Therapeutic rationale for antithrombin III in sepsis // Crit. Care Med. 2000. Vol. 28, № 9. P. 34-37.Opal S. M. Therapeutic rationale for antithrombin III in sepsis // Crit. Care Med. 2000. Vol. 28, № 9. P. 34-37.Otowa K., Takamura M., Murai H. et al. Altered interaction between plasminogen activator inhibitor type 1 activity and sympathetic nerve activity with aging // Circ. J. 2008. Vol. 72, № 3. P. 458-462.Otowa K., Takamura M., Murai H. et al. Altered interaction between plasminogen activator inhibitor type 1 activity and sympathetic nerve activity with aging // Circ. J. 2008. Vol. 72, № 3. P. 458-462.Paneni F., Beckman J. A., Creager M. A. et al. Cosentino diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy // Eur. Heart J. 2013. Vol. 4, № 31. P. 2436-2443.Paneni F., Beckman J. A., Creager M. A. et al. Cosentino diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy // Eur. Heart J. 2013. Vol. 4, № 31. P. 2436-2443.Parienti J., Mongardon N., Mégarbane B. et al. Intravascular complications of central venous catheterization by insertion site // N. Engl. J. Med. 2015. Vol. 373, № 13. P. 1220-1229.Parienti J., Mongardon N., Mégarbane B. et al. Intravascular complications of central venous catheterization by insertion site // N. Engl. J. Med. 2015. Vol. 373, № 13. P. 1220-1229.Ratib S., Walker A. J., Card T. R. et al. Risk of venous thromboembolism in hospitalised cancer patients in England-a cohort study // J. Hematol. Oncol. 2016. Vol. 26, № 1. P. 60. doi: 10.1186/ s13045-016-0291-0.Ratib S., Walker A. J., Card T. R. et al. Risk of venous thromboembolism in hospitalised cancer patients in England-a cohort study // J. Hematol. Oncol. 2016. Vol. 26, № 1. P. 60. doi: 10.1186/ s13045-016-0291-0.Rosendaal F. R. Causes of venous thrombosis // Thromb. J. 2016. Vol. 4, № 14 (Suppl. 1). P. 24. doi: 10.1186/s12959-016-0108-y.Rosendaal F. R. Causes of venous thrombosis // Thromb. J. 2016. Vol. 4, № 14 (Suppl. 1). P. 24. doi: 10.1186/s12959-016-0108-y.Schmidt M., Horvath-Puho E., Thomsen R. W. et al. Acute infections and venous thromboembolism // J. Intern. Med. 2012. Vol. 271, № 6. P. 608-618.Schmidt M., Horvath-Puho E., Thomsen R. W. et al. Acute infections and venous thromboembolism // J. Intern. Med. 2012. Vol. 271, № 6. P. 608-618.Sorensen H. T., Mellemkjaer L., Olsen J. H., Baron J. A. Prognosis of cancers associated with venous thromboembolism // N. Engl. J. Med. 2000. Vol. 343, № 25. P. 1846-1850.Sorensen H. T., Mellemkjaer L., Olsen J. H., Baron J. A. Prognosis of cancers associated with venous thromboembolism // N. Engl. J. Med. 2000. Vol. 343, № 25. P. 1846-1850.Tesselaar M. E., Romijn F. P., Van Der Linden I. K. et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? // J. Thromb. Haemost. 2007. Vol. 5, № 3. Р. 520-527.Tesselaar M. E., Romijn F. P., Van Der Linden I. K. et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? // J. Thromb. Haemost. 2007. Vol. 5, № 3. Р. 520-527.Wu O., Robertson L., Twaddle S. et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study // Health Technol. Assess. 2006. Vol. 10, № 11. P. 1-110.Wu O., Robertson L., Twaddle S. et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study // Health Technol. Assess. 2006. Vol. 10, № 11. P. 1-110.
The authors declare that there are no conflicts of interest present.